MEGAN WANG to Middle Aged
This is a "connection" page, showing publications MEGAN WANG has written about Middle Aged.
Connection Strength
0.015
-
Sustained benefit of zanubrutinib vs ibrutinib in patients with R/R CLL/SLL: final comparative analysis of ALPINE. Blood. 2024 Dec 26; 144(26):2706-2717.
Score: 0.015